SequelSEC

CareDx, Inc. CDNA

Services-Medical Laboratories · CIK 0001217234 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$497.40M
Fiscal year ended 2026-09-30
Operating income
$116.49M
Fiscal year ended 2026-09-30
Free cash flow
Unavailable
Fiscal year ended 2026-09-30

Valuation, from the filing

Public float$1.00BMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$19.53Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity3.3×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Medical Laboratories filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Net margin-5.6%67th
Operating margin-8.1%67th
R&D / revenue18.8%56th
Revenue YoY growth13.8%45th
SBC / revenue9.2%55th
Current ratio2.86x48th

CareDx, Inc. (CDNA) reported revenue of $497.40M and net income of $128.63M for the fiscal year ended 2026-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from CareDx, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

CareDx, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Revenue$497.40M
Cost of revenueUnavailable
Gross profitUnavailable
Operating income$116.49M
Net income$128.63M
Research & development$84.42M
Weighted-average diluted sharesUnavailable
Pretax income$124.22M
Income tax expense-$4.41M
Diluted EPSUnavailable
Selling, general & administrative$264.45M
General & administrative$138.06M
Selling & marketing$126.39M

Balance

CareDx, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Cash & equivalents$250.48M
Total assets$641.46M
Current assets$321.30M
Total liabilities$174.00M
Current liabilities$138.98M
Total equity incl. NCI$467.46M
Temporary (mezzanine) equityUnavailable
Inventory$9.14M
Accounts receivable$47.73M
Goodwill$121.71M
Long-term debtUnavailable
Accounts payable$10.81M

Cash flow

CareDx, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Operating cash flow$69.02M
Capital expendituresUnavailable
Investing cash flow$108.85M
Financing cash flow-$17.97M
Net change in cash$159.90M
Stock-based compensation$38.20M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$17.80M

Derived

CareDx, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Free cash flowUnavailable
Gross marginUnavailable
Operating margin23.4%
FCF marginUnavailable
SBC / revenue7.7%
Current ratio2.31x
Revenue YoY growth38.9%
Net margin25.9%
R&D / revenue17.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rate-3.5%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CDNA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-29View SEC filing
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-28View SEC filing
10-K · Filed 2026-02-25View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-06View SEC filing

Companies in the same industry

ACON ADVB AMS BDSX BGLC BLLN CAI CELC CFOR CSTL DGX FCHS

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.